Research reported at Medicalxpress.,com stated that a new method of minimizing the number of missed cases of cervical cancer and making the diagnoses more reliable has been found that may decrease the number of deaths annually. Despite a reduction in the number of women diagnosed with and dying from cervical cancer there are still 250 deaths and 500 new cases annually in Sweden.
The test currently used has a low sensitivity requiring cell samples to be taken at least every three years. Unreliable results also mean many tests must be repeated adding cost to care and anxiety among women involved. The new test is a complementary test that minimize4s the number of missed cases. The researcher says “Around 70 per cent of all cervical cancer cases are caused by two specific virus types, known as HPV16 and HPV18. We have developed a method that identifies proteins of these oncogenic viruses in cells, enabling a more objective interpretation of the test results.” Researchers believe this will produce a more reliable diagnosis in uncertain cases and reduce missed cases and recalling women with samples that are difficult to interpret.